Pulmonx Corp (LUNG)

Pulmonx Corp (LUNG) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $77.3M; returns 1 day -2.7%, 1 week +2.8%, 1 year +15.1%.

Pulmonx Corp is a commercial-stage medical device company focused on developing and commercializing minimally invasive treatments for patients suffering from severe emphysema, a debilitating form of Chronic Obstructive Pulmonary Disease (COPD).

Groups LUNG belongs to

• Medical Devices
• Chronic Obstructive Pulmonary Disease (COPD)
• Minimally Invasive Surgery
• Commercial Stage
• Healthcare
• Healthcare Technology
• Health Diagnostics and Imaging

LUNG financial model: income statement, cash flow and balance sheet